title: New therapies in the treatment of overactive bladder.
abstract: BACKGROUND
  Overactive bladder (OAB) is a common condition which affects both men and women across many age groups with significant impact on quality of life. There is currently an armamentarium of treatment options available ranging from conservative, medical therapy to radical surgeries. Increasing understanding of OAB is resulting in the rapid development of new therapies today.
  
  
  METHODS
  The purpose of this article was to summarise the latest developments in non-neurogenic OAB treatment, discuss the evidence and results of current and new treatment modalities available through review of published data and results presented at recent international meetings.
  
  
  CONCLUSIONS
  The ultimate goal in OAB therapy is to provide good clinical efficacy, safe, non-invasive and easy to administer. There is definitely room for development of new therapies in OAB and current progress is encouraging.
authors.affiliation: Bristol Urological Institute, Southmead Hospital, Bristol, BS10 5NB, UK. syek1904@yahoo.com.sg
authors.forename: Eu Kiang Sharon
authors.initials: EK
authors.lastname: Yeo
authors.forename: Hashim
authors.initials: H
authors.lastname: Hashim
authors.forename: Paul
authors.initials: P
authors.lastname: Abrams
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000818:Animals; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D004561:Transcutaneous Electric Nerve Stimulation; D053201:Urinary Bladder, Overactive / Q000628:therapy*
chemical_list: D000318:Adrenergic beta-Agonists; D018727:Muscarinic Antagonists; D019274:Botulinum Toxins, Type A